“...pleasure and pain, they come and go and don't last... bear them patiently”
—Gita
Pathos InvestmentsEquity Research
Research  ›  Fact Sheets  ›  DVA

DAVITA INC.

LISTEDNYSE
SYMBOLDVA
SIC8090
STATE OF INC.DE
FISCAL YEAR ENDSDecember 31
CIK927066

SERVICES-MISC HEALTH & ALLIED SERVICES, NEC · LARGE ACCELERATED FILER · 10 FISCAL YEARS OF SEC XBRL DATA, 2016–2025

REVENUES, NET INCOME AND FREE CASH FLOW BY FISCAL YEAR$ billions0510152016201720182019202020212022202320242025RevenuesNet incomeFree cash flowEARNINGS AND DIVIDENDS PER SHARE$ per share0.005.0010.0015.002016201720182019202020212022202320242025EPS dilutedDividends per share

Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures as reported.

CAPITALIZATION 12/31/25

($ millions)Amount%
Total debt10,273106.8
Stockholders' equity(651)-6.8
Total capitalization9,622100.0

63,800,000 shares outstanding at 31 July 2026 (cover page of the 10-Q filed 4 August 2026).

LONG-TERM DEBT 12/31/25

($ millions)Amount
Long-term debt, incl. current maturities10,273
Long-term debt, noncurrent10,164
Current maturities109

CAPITAL STOCK 12/31/25

Common shares authorized450,000,000
Common shares issued68,549,000
Treasury shares0
Par or stated value per share ($)0.001
Preferred stock ($ millions)0
Outstanding at 7/31/2663,800,000

DIVIDENDS DECLARED/PAID

Fiscal yearPer share $Payout %
2025––
2024––
2023––
2022––
2021––

HISTORY AND BUSINESS

HISTORY: Incorporated in Delaware. Formerly known as DAVITA HEALTHCARE PARTNERS INC. (to 12 August 2016); TOTAL RENAL CARE HOLDINGS INC (to 28 January 2000).

BUSINESS: Classified by the SEC under Standard Industrial Classification 8090, Services-Misc Health & Allied Services, NEC. Large accelerated filer. Principal executive office: 2000 16Th Street, Denver, CO 80202. Fiscal year ends December 31. For a description of the business, see Item 1 of the latest 10-K.

CONSOLIDATED INCOME ACCOUNT, YEARS ENDED

($ millions)12/31/2512/31/2412/31/23
Revenues13,64312,81612,140
Depreciation and amortization708716736
Operating income2,0442,0901,603
Interest expense540435374
Income before income taxes1,3471,5301,177
Income taxes293280220
Net income747936692
Earned per share, diluted ($)9.8410.737.42
Dividends per share ($)–––

CONSOLIDATED BALANCE SHEET

($ millions)12/31/2512/31/24
Cash and equivalents676795
Receivables, net2,4152,147
Inventories161135
Total current assets4,0583,746
Property, plant and equipment, net2,8132,941
Goodwill7,5457,375
Total assets17,48017,285
Total current liabilities3,1422,973
Long-term debt10,1649,176
Total liabilities16,32215,194
Stockholders' equity(651)121
Total liabilities and equity17,48017,285

TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)

Fiscal year endedRevenuesOper. incomeNet incomeNet margin %EPS diluted $Div. per share $Oper. cash flowCapital expend.Free cash flowTotal assetsTotal liabilitiesTotal debtStockholders' equityROE %Debt / equity
12/31/2513,6432,0447475.59.84–1,8865761,31117,48016,32210,273(651)-114.7-15.78
12/31/2412,8162,0909367.310.73–2,0225551,46717,28515,1949,447121773.177.99
12/31/2312,1401,6036925.77.42–2,0595681,49116,89414,1508,3921,05665.57.95
12/31/2211,6101,3395604.85.85–1,56560396116,92814,7038,92471278.712.53
12/31/2111,6191,7979788.48.90–1,9316411,28917,12114,7518,908756129.511.79
12/31/2011,5511,6957746.76.31–1,9796751,30416,98914,0928,0861,38455.95.84
12/31/1911,3881,6438117.15.27–2,0727671,30617,31113,8128,1082,13338.03.80
12/31/1811,4051,5261591.40.92–1,77298778519,11014,07710,1023,7034.32.73
12/31/1710,8771,8136646.13.47–1,9139051,00818,97513,0779,3364,69014.11.99
12/31/1610,7072,0308808.24.29–1,9728291,14318,75612,9339,1054,64818.91.96

Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; free cash flow = operating cash flow − purchases of property, plant and equipment; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.

REGISTRANT:

DAVITA INC.
CIK 927066 · EIN 51-0354549

PRINCIPAL OFFICE:

2000 16Th Street, Denver, CO 80202
Tel.: 310-536-2668

INCORPORATED:

Delaware

INDUSTRY (SEC SIC CODE):

8090 · Services-Misc Health & Allied Services, NEC

FILER STATUS:

Large accelerated filer

LATEST ANNUAL REPORT:

10-K for period ended 12/31/25, filed 11 February 2026

FORMER NAMES:

DAVITA HEALTHCARE PARTNERS INC.; DAVITA INC; TOTAL RENAL CARE HOLDINGS INC

RECENT FILINGS (ANNUAL REPORT REFERENCES BELOW):

8/4/2610-Qperiod 6/30/26
8/4/268-Kperiod 8/4/26
6/8/268-Kperiod 6/4/26
5/5/2610-Qperiod 3/31/26
5/5/268-Kperiod 5/5/26
4/22/26DEF 14Aperiod 12/31/25
2/11/2610-Kperiod 12/31/25
2/2/268-Kperiod 2/2/26

Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2025 (filed 2/11/26) · 10-K FY2024 (filed 2/13/25) · 10-K FY2023 (filed 2/14/24) · 10-K FY2022 (filed 2/22/23) · 10-K FY2021 (filed 2/11/22) · 10-K FY2020 (filed 2/12/21) · 10-K FY2019 (filed 2/21/20) · 10-K FY2018 (filed 2/22/19). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.

Data from SEC filings. © 2026 Pathos Investments · pathosinvestments.com · For educational purposes only. Not investment advice.

Data from SEC filings  ·  Educational only  ·  Not investment advice